An Interactive AI Agent for Personalized Glycemic Management in Type 1 Diabetes: A Pilot Randomized Controlled Trial
5/22/2025 • Journal of Medical Internet Research • License: CC BY
Garcia, C.
Abstract
This pilot RCT evaluated an AI agent designed to support patients with Type 1 Diabetes. The agent monitored data from continuous glucose monitors, interacted with patients via a smartphone app to provide coaching, and autonomously suggested insulin dose adjustments for clinician approval. Patients using the AI agent achieved a 12% greater time-in-range for blood glucose levels and reported higher treatment satisfaction compared to the control group.
Source: View original
Clinical implications
In a clinical trial, a new AI agent acted as a virtual coach for patients with Type 1 Diabetes. It monitored their glucose levels and suggested insulin dose changes. Patients using the agent had better blood sugar control and were more satisfied with their care.
This product uses publicly available data from the U.S. National Library of Medicine (NLM),
National Institutes of Health, Department of Health and Human Services; NLM is not responsible
for the product and does not endorse or recommend this or any other product.
Links to third-party publications are provided for research discovery.